Clinical Trials

  • Principal Investigator:

    Ilene Fennoy, MD
    We are doing this research study to find out what happens to children who are overweight and how the things we recommend as a part of routine clinical care affect your child. The purpose of this study is to understand what happens to children as a result of being overweight, to link these outcomes to specific clinical measures, and to determine how treatment affects the physical and clinical features of overweight or obesity. To achieve this aim we want to formalize our ongoing clinical chart review into a database for our patients.
  • Principal Investigator:

    Melissa S. Stockwell, MD
    The purpose of this study is to assess the effectiveness of influenza and SARS-CoV-2 vaccines for preventing transmission of infections in households. We are seeking volunteers who have been recently diagnosed with COVID-19 or Influenza virus infection by either rapid diagnostic assay or RT-PCR in the last 7 days and live in a household with at least one other person. The study, also known as RVTN Sentinel Respiratory VirusTransmission Network will be looking at household transmission of SARS-CoV-2 and/or influenza. Once someone and their household contacts are enrolled, they will be followed...
  • Principal Investigator:

    Melissa S. Stockwell, MD
    The purpose of this study is to assess the effectiveness of influenza and SARS-CoV-2 vaccines for preventing transmission of infections in households. We are seeking volunteers who have been recently diagnosed with COVID-19 or Influenza virus infection by either rapid diagnostic assay or RT-PCR in the last 7 days and live in a household with at least one other person. The study, also known as RVTN Sentinel Respiratory VirusTransmission Network will be looking at household transmission of SARS-CoV-2 and/or influenza. Once someone and their household contacts are enrolled, they will be followed...
  • Principal Investigator:

    Prakash Satwani, MD
    Are you undergoing a stem cell transplant? You may be at high risk for infections after the transplant. This study is looking at the safety and effectiveness of an investigational medication for those who have undergone a stem cell transplant. Recovery after a stem cell transplant can already be challenging without the added worry of life-threatening viral reinfections. It may be worth exploring the possibilities and peace of mind a clinical trial can offer. This is a Phase 2/3 study to evaluate the efficacy and safety of ALVR105 (also known as Viralym-M and formerly known as ALVR-105) for...

Pages